Some Blood Pressure Meds May Boost Risk for Mood Disorders

People who take certain blood pressure-lowering medications may be at an elevated risk of developing mood disorders, including depression and bipolar disorder.

Researchers examined data on more than 144,000 adults with an average age of 56. Just over 32,000 of them were taking one of 4 types of drug to treat their hypertension: angiotensin agonists (ACE inhibitors and angiotensin receptor blockers), beta blockers, calcium channel blockers and thiazide diuretics.

Common angiotensin agonists include Cozaar (losartan), Diovan (valsartan), Lotensin (benazepril) and Altace (ramipril); common beta blockers are Lopressor (metoprolol), Coreg (carvedilol) and atenolol; common calcium channel blockers include Norvasc (amlodipine) and Cardizem (diltiazem); and common thiazide diuretics include hydrochlorothiazide (HCTZ, HCT, HCZ).

Over a 5-year period, those on a beta blocker or calcium channel blocker were twice as likely to have been hospitalized for a mental illness (mostly depression) compared to those on an angiotensin agonist, the researchers reported in the journal Circulation.

People on an angiotensin agonist were also 50% less likely to be hospitalized with a mood disorder compared to those who weren’t on any hypertension drug. And those taking a thiazide diuretic had no impact on risk for hospitalization.

It’s important to note that the study was observational in nature, meaning the researchers aren’t sure exactly what led to the increase in mood disorders with some of these drugs. However, the results may indicate that patients with high blood pressure that are at risk for mood disorders could be better off with an angiotensin agonist.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Latest News

Covid-19: Side Effects of Trump’s Treatments

Covid-19: Side Effects of Trump’s Treatments

President Donald Trump announced (via Twitter, of course) what some considered unthinkable, and others considered inevitable — that he had tested positive for Covid-19. Over the weekend, he received various treatments  — supplements like vitamin D, zinc and melatonin, an experimental antibody combination, an antiviral drug and a powerful anti-inflammatory…

Un-Sheltering Tips for Your Health and Immune System

Un-Sheltering Tips for Your Health and Immune System

As we all emerge from our bubbles of limited contact with others, we are walking straight into the double whammy of flu season and COVID-19 germs. Can your body fight off exposure to the flu and COVID? Your immune system feeds off the basics of life — sleep, movement, food…